search
Back to results

Left Bundle Branch Pacing Versus Biventricular Pacing for Cardiac Resynchronization Therapy (LBBP-RESYNC)

Primary Purpose

Chronic Heart Failure

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Left bundle branch pacing
Biventricular pacing
Sponsored by
The First Affiliated Hospital with Nanjing Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Heart Failure focused on measuring cardiac resynchronization therapy, chronic heart failure, left bundle branch pacing, biventricular pacing

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. LVEF≤35% as assessed by echocardiography and NYHA class II-IV despite optimal medical therapy for at lest 3 months;
  2. Sinus rhythm, complete left bundle branch block (QRS duration ≥130ms);
  3. Between the ages of 18 and 80;
  4. With informed consent signed.

Exclusion Criteria:

  1. After mechanical tricuspid valve replacement;
  2. Unstable angina, acute MI, CABG or PCI within the past 3 months;
  3. Persistent atrial fibrillation without atrioventricular block, the expected percentage of ventricular pacing below 95%;
  4. Enrollment in any other study;
  5. A life expectancy of less than 12 months;
  6. Pregnant or with child-bearing potential;
  7. History of heart transplantation.

Sites / Locations

  • The First Affiliated Hospital with Nanjing Medical University
  • Fu Wai Hospital, Beijing, China

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

LBBP group

BivP group

Arm Description

In this arm, An right artrial (RA) lead and an implantable cardioverter defibrillator (ICD) lead are conventionally implanted. A left bundle branch pacing(LBBP) lead is attempted to be placed. If LBBP failed, a left ventricular(LV) pacing lead is implanted instead.

In this arm, an RA lead , an ICD lead and a LV pacing lead are placed. If the implantation of LV pacing lead is unsuccessful due to unavailable coronary sinus branches(venae cordis magna or venae cordis media is not recommended), capture above 3.5V/0.5ms or refractory phrenic nerve stimulation,a LBBP lead is placed instead.

Outcomes

Primary Outcome Measures

Echocardiography parameters(LVEF,LVESV and LVEDV)
Changes in LVEF,LVESV and LVEDV between baseline and follow-up

Secondary Outcome Measures

Paced QRS duration
Paced QRS duration is evaluated postoperative day 1 and 1 months, 3 months and 6 months after implantation.
Changes in concentration of NT-proBNP in blood between baseline and follow-up
Blood test is performed at each time frame to determine the concentration of NT-proBNP(unit: pg/mL)
Changes in New York Heart Association Heart Function Classification between baseline and follow-up
The higher the classification, the more severe the heart failure symptoms(four levels: I, II, III and IV)
Changes in 6-minute Walk Distance between baseline and follow-up
Distance that a participant walk within 6 minutes
Change in Quality Of Life Questionnaire score between baseline and follow-up
Reflect the effect of heart failure on quality of life, and higher scores represent a worse outcome
Incidence of clinical adverse events
Including date and number of all-cause mortality, heart failure hospitalization, cardiovascular hospitalization and malignant ventricular arrhythmia

Full Information

First Posted
September 23, 2019
Last Updated
March 16, 2022
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Fu Wai Hospital, Beijing, China
search

1. Study Identification

Unique Protocol Identification Number
NCT04110431
Brief Title
Left Bundle Branch Pacing Versus Biventricular Pacing for Cardiac Resynchronization Therapy
Acronym
LBBP-RESYNC
Official Title
Comparison Between Left Bundle Branch Pacing and Biventricular Pacing for Cardiac Resynchronization Therapy in Heart Failure(LBBP-RESYNC)
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
November 14, 2019 (Actual)
Primary Completion Date
June 29, 2021 (Actual)
Study Completion Date
June 29, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Fu Wai Hospital, Beijing, China

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The present study will recruit 40 symptomatic heart failure patients with left ventricular ejection fraction (LVEF) below 35% and complete left bundle branch block(QRSd≥130 ms). Each patient was randomized to either left bundle branch pacing(LBBP) or biventricular pacing(BivP) and was followed up for at least 6 months. The objective is to compare the effects of LBBP and BivP on cardiac resynchronization in the treatment of heart failure by measurable clinical parameters.
Detailed Description
The traditional biventricular pacing (BivP) is an established treatment to corrected the cardiac dyssynchrony in heart failure patients with left bundle branch block(LBBB). It has been proved that BivP can improve clinical symptoms and reduce all-cause mortality in heart failure. However, BivP is subject to the variable coronary sinus(CS) anatomy and LV-pacing lead fail to be implanted in 5%-10% of patients due to the lack of appropriate target branch, high threshold or phrenic nerve stimulation. Almost 30%-40% of patients with successful implantation show no response. What's more, BivP just corrects the mechanical dyssynchrony caused by LBBB not corrects the LBBB. Recent studies have demonstrated that His bundle pacing (HBP) can correct LBBB, achieve physiological pacing and realize the cardiac resynchronization. But HBP has high technical requirements, lower sense value and higher threshold of correcting LBBB, which may be further increased in long-term follow-up. The lastest research shows that pacing left ventricular septum using a transseptal approach can reduce left ventricular(LV) electrical dyssynchrony. Huang et al first confirmed that left bundle branch pacing(LBBP) can correct LBBB and improve cardiac function. LBBP has been reported to offer higher success rate with higher sense value and lower pacing thresholds compared with HBP. In chronic heart failure patients with LBBB that need cardiac resynchronization therapy(CRT), LBBP can achieve the similar electrical and mechanical resynchronization as well as HBP. There is to date no randomized studies between LBBP and BivP in HFrEF patients with complete LBBB that need CRT. The purpose of this study is to compare the therapeutic effects of LBBP and conventional BivP on LV function and clinical endpoints in such patients. The present study will randomize 40 patients in two centres to LBBP or BivP. Baseline assessments including echocardiography parameters[left ventricular ejection fraction(LVEF ), left ventricular end-systolic volume(LVESV), left ventricular end-diastolic volume(LVEDV)], electrocardiogram(ECG), N-terminal pro B-type natriuretic peptide(NT-proBNP) level, New York Heart Association(NYHA) class, 6-minute walking distance(6MWD) and quality of life score(QOL) will be obtained. At the same time, the LBBP and BivP success rate, intraoperative and postoperative complications are recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Heart Failure
Keywords
cardiac resynchronization therapy, chronic heart failure, left bundle branch pacing, biventricular pacing

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
LBBP group
Arm Type
Experimental
Arm Description
In this arm, An right artrial (RA) lead and an implantable cardioverter defibrillator (ICD) lead are conventionally implanted. A left bundle branch pacing(LBBP) lead is attempted to be placed. If LBBP failed, a left ventricular(LV) pacing lead is implanted instead.
Arm Title
BivP group
Arm Type
Active Comparator
Arm Description
In this arm, an RA lead , an ICD lead and a LV pacing lead are placed. If the implantation of LV pacing lead is unsuccessful due to unavailable coronary sinus branches(venae cordis magna or venae cordis media is not recommended), capture above 3.5V/0.5ms or refractory phrenic nerve stimulation,a LBBP lead is placed instead.
Intervention Type
Procedure
Intervention Name(s)
Left bundle branch pacing
Intervention Description
Successful LBBP was defined as (1) LBBP lead is located at 1.5-2cm from His-bundle towards right ventricular apex; (2) Paced QRS morphology of right bundle branch delay(CRBBD) in lead V1; (3) Stimulus to the peak of R wave in V5 and V6 QRS wave, which represents left ventricular activation time(Stim-LVAT), is less than 100ms and constant at high and low output pacing; (4) Unipolar pacing threshold<1.5V/0.5ms; (5) Recording P potential when narrow QRS escape rhythm or CRBBB escape rhythm(not essential).
Intervention Type
Procedure
Intervention Name(s)
Biventricular pacing
Intervention Description
Implantation of a LV pacing lead is attempted using the standard-of-care technique first.
Primary Outcome Measure Information:
Title
Echocardiography parameters(LVEF,LVESV and LVEDV)
Description
Changes in LVEF,LVESV and LVEDV between baseline and follow-up
Time Frame
Baseline; 6-month follow-up
Secondary Outcome Measure Information:
Title
Paced QRS duration
Description
Paced QRS duration is evaluated postoperative day 1 and 1 months, 3 months and 6 months after implantation.
Time Frame
Postoperative day 1; 1-month,3-month and 6-month follow-upP
Title
Changes in concentration of NT-proBNP in blood between baseline and follow-up
Description
Blood test is performed at each time frame to determine the concentration of NT-proBNP(unit: pg/mL)
Time Frame
Baseline; 1-month,3-month and 6-month follow-up
Title
Changes in New York Heart Association Heart Function Classification between baseline and follow-up
Description
The higher the classification, the more severe the heart failure symptoms(four levels: I, II, III and IV)
Time Frame
Baseline; 1-month,3-month and 6-month follow-up
Title
Changes in 6-minute Walk Distance between baseline and follow-up
Description
Distance that a participant walk within 6 minutes
Time Frame
Baseline; 1-month,3-month and 6-month follow-up
Title
Change in Quality Of Life Questionnaire score between baseline and follow-up
Description
Reflect the effect of heart failure on quality of life, and higher scores represent a worse outcome
Time Frame
Baseline; 1-month,3-month and 6-month follow-up
Title
Incidence of clinical adverse events
Description
Including date and number of all-cause mortality, heart failure hospitalization, cardiovascular hospitalization and malignant ventricular arrhythmia
Time Frame
6-month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: LVEF≤35% as assessed by echocardiography and NYHA class II-IV despite optimal medical therapy for at lest 3 months; Sinus rhythm, complete left bundle branch block (QRS duration ≥130ms); Between the ages of 18 and 80; With informed consent signed. Exclusion Criteria: After mechanical tricuspid valve replacement; Unstable angina, acute MI, CABG or PCI within the past 3 months; Persistent atrial fibrillation without atrioventricular block, the expected percentage of ventricular pacing below 95%; Enrollment in any other study; A life expectancy of less than 12 months; Pregnant or with child-bearing potential; History of heart transplantation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jiangang Zou, MD,Ph.D
Organizational Affiliation
The First Affiliated Hospital with Nanjing Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The First Affiliated Hospital with Nanjing Medical University
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210029
Country
China
Facility Name
Fu Wai Hospital, Beijing, China
City
Beijing
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29173611
Citation
Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Ellenbogen KA. A Novel Pacing Strategy With Low and Stable Output: Pacing the Left Bundle Branch Immediately Beyond the Conduction Block. Can J Cardiol. 2017 Dec;33(12):1736.e1-1736.e3. doi: 10.1016/j.cjca.2017.09.013. Epub 2017 Sep 22.
Results Reference
background
PubMed Identifier
31322651
Citation
Hou X, Qian Z, Wang Y, Qiu Y, Chen X, Jiang H, Jiang Z, Wu H, Zhao Z, Zhou W, Zou J. Feasibility and cardiac synchrony of permanent left bundle branch pacing through the interventricular septum. Europace. 2019 Nov 1;21(11):1694-1702. doi: 10.1093/europace/euz188.
Results Reference
background
PubMed Identifier
26888445
Citation
Mafi-Rad M, Luermans JG, Blaauw Y, Janssen M, Crijns HJ, Prinzen FW, Vernooy K. Feasibility and Acute Hemodynamic Effect of Left Ventricular Septal Pacing by Transvenous Approach Through the Interventricular Septum. Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e003344. doi: 10.1161/CIRCEP.115.003344.
Results Reference
background
PubMed Identifier
36137670
Citation
Wang Y, Zhu H, Hou X, Wang Z, Zou F, Qian Z, Wei Y, Wang X, Zhang L, Li X, Liu Z, Xue S, Qin C, Zeng J, Li H, Wu H, Ma H, Ellenbogen KA, Gold MR, Fan X, Zou J; LBBP-RESYNC Investigators. Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2022 Sep 27;80(13):1205-1216. doi: 10.1016/j.jacc.2022.07.019.
Results Reference
derived

Learn more about this trial

Left Bundle Branch Pacing Versus Biventricular Pacing for Cardiac Resynchronization Therapy

We'll reach out to this number within 24 hrs